Research Library
LIMITED / EMERGING

Semax

Also known as: Semax, ACTH(4-7) analog

NeurobiologyPeptide Signaling
ClassificationSynthetic peptide (ACTH(4-7) analog).
Catalog / SKUSemax · MX-SEMAX-010 · 10 mg
TargetsBDNF-related / neurotrophic pathways (reported)

Molecular Overview

Semax is a synthetic peptide related to a fragment of ACTH studied in experimental neurobiology, with reported associations to neurotrophic signalling (e.g., BDNF) in research models, much of it from Russian literature.

Mechanistic Background

Reported experimental effects on neurotrophic factors and neuromodulation; mechanisms remain under investigation.

What Researchers Study

Experimental research has examined neuroprotective and cognitive-related endpoints.

Evidence Landscape

Current evidence level: LIMITED / EMERGING. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Evidence is limited and largely from a narrow set of sources.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.